Has Rolando Izquierdo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $121,285 in general payments to Rolando Izquierdo, MD across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rolando Izquierdo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rolando Izquierdo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rolando Izquierdo, MD

Orthopaedic Surgery · Algonquin, ILNPI 1134138027

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.6%), royalties or licence payments and food and beverage — rather than concentrated in one kind of arrangement. Limacorporate S.p.a. accounts for 86.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $46,499 and has fallen 98.8% since, to $552 in 2025. Among orthopaedic surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$121,285in general payments, 2019–2025

Across 77 payments — averaging $1575.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Limacorporate S.p.a.$105K
Lima USA, Inc.$14K
Exactech, Inc.$1K
Stryker$390
Arthrex$270
Amgen$153
plus $476 from 6 others

$11,642in research payments, 2019–2025

Across 4 payments — averaging $2910.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Limacorporate S.p.a.$12K

$48,881in ownership & investment interests, 2019–2025

Across 6 payments — averaging $8146.87 each. An ownership or investment interest held by the physician or an immediate family member.

Catalyst Orthoscience$49K

What the payments were for

Royalty or licence$56,46847%
Consulting fees$57,73648%
Travel & lodging$3,3533%
Food & beverage$3,7283%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Limacorporate S.p.a.	21	$104,969
Lima USA, Inc.	32	$13,987
Exactech, Inc.	6	$1,040
Stryker	4	$390
Arthrex	4	$270
Amgen	2	$153
Xiros Inc	1	$152
Encore Medical, LP	2	$151
Linvatec Corporation	2	$74
Oak Med, Inc.	1	$58
Pacira Pharmaceuticals Incorporated	1	$30
Johnson & Johnson	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SMR Shoulder$60,790
SMR$56,497
ACCELERATE II PLATELET CONCENTRATING SYSTEM 60ML$502
Prima$500
EQUINOXE$455
Product Portfolio$404
BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$314
N/A$152

How this compares

$121,285 in reported general payments places this provider in the 90th percentile of 844 orthopaedic surgery providers in Illinois.

See all orthopaedic surgery providers in Illinois →

Medicare billing

Part B allowed, 2024

$337,823

Medicare patients

739

Services billed

2,820

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Vancomycin Hcl	11	$697
Methylprednisolone	85	$403
Amoxicillin	117	$110
Meloxicam	35	$91
Clindamycin Hcl	45	$57

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Algonquin

Peter BonuttiEffingham$24.3M
Steven HaddadGlenview$12.6M
Aaron RosenbergChicago$12.4M
Treg BrownHerrin$6.6M
Wayne GoldsteinMorton Grove$4.9M
Steven ChudikWestmont$4.1M
Matthew SquireAurora$2.9M
David ManningBurr Ridge$2.3M
Ritesh ShahMorton Grove$2.3M
Anish KadakiaChicago$2.1M

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →